United States · FDA National Drug Code directory
LISINOPRIL AND HYDROCHLOROTHIAZIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-9808_2cc3b3fe-d9b9-4058-b12c-541cea1d6682
- Product NDC
- 68788-9808
- Form
- TABLET
- Composition / generic term
- LISINOPRIL AND HYDROCHLOROTHIAZIDE
- Labeler
- Preferred Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120423
- Source listing expiry
- 20271231
Source-listed ingredients
- HYDROCHLOROTHIAZIDE — 25 mg/1
- LISINOPRIL — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (68788-9808-1) · 68788-9808-1
- 30 TABLET in 1 BOTTLE (68788-9808-3) · 68788-9808-3
- 60 TABLET in 1 BOTTLE (68788-9808-6) · 68788-9808-6
- 90 TABLET in 1 BOTTLE (68788-9808-9) · 68788-9808-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →